Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PBPH vs. SLMCX: which is better?

Bottom line

PBPH vs SLMCX: the short answer

PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) and SLMCX (Columbia Seligman Technology and Information Fund) are both etfs.

SLMCX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

PBPH vs SLMCX side by side

PBPHSLMCX
TypeETFMutual fund
Fund familyBuilding Block World Pharma And Biotech IndexColumbia Threadneedle
CategoryTechnology SectorTechnology Sector
Expense ratio—1.14%
Annual cost per $10k—$114
10-yr cost on $10k (prospectus)—$1,881
Max front loadNone5.75%
12b-1 fee—0.25%
1-yr return—+29.5%
5-yr return (annualized)—+17.7%
10-yr return (annualized)—+21.8%
Best quarter—+31.5%
Worst quarter—−21.1%
Net assets (fund)—$28.2B
Number of holdings—85
Portfolio turnover—47%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

PBPH and SLMCX share none of their top holdings.

PBPH top 10

    SLMCX top 10

    1. Bloom Energy Corp — 10.24%
    2. Lam Research Corp — 7.51%
    3. Columbia Short Term Cash Fund — 6.34%
    4. Marvell Technology Inc — 6.19%
    5. Broadcom Inc — 4.66%
    6. NVIDIA Corp — 4.35%
    7. Western Digital Corp — 4.15%
    8. Applied Materials Inc — 3.86%
    9. Alphabet Inc — 3.82%
    10. Apple Inc — 2.90%

    FAQ

    What is the difference between PBPH and SLMCX?
    PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) and SLMCX (Columbia Seligman Technology and Information Fund) are both etfs. SLMCX has a front-end sales load of up to 5.75%; the other does not.
    Should I own both PBPH and SLMCX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.